Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
NCT ID: NCT00447850
Last Updated: 2009-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2007-04-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
NCT06280560
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
NCT05405686
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
NCT04499131
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
NCT03755973
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
NCT02322398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endometrial biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18-35 years old
* BMI 18-29
* NORMOGONADOTROPHICS
* PROGESTERONE ≥ 1.2 ng/ml on hCG day
Exclusion Criteria
* Endometriosis
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Valenciano de Infertilidad, IVI VALENCIA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Instituto Valenciano de Infertilidad
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Labarta, MD
Role: PRINCIPAL_INVESTIGATOR
Instituto Valenciano de la Infertilidad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ivi Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VLC-EL-1006- 307-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.